As the world leader for nonwovens manufacturing, Berry Global Group Inc. is supplying leading healthcare and consumer brand companies around the world to create products in high demand to fight spread of the coronavirus.
In its January 31 announcement, Berry reported the prioritization of health care production in its Chinese facilities in response to the increased demand for coronavirus prevention. Concurrently, the company has responded to this increased demand across North America and Europe. In the United States, Berry has shifted capacity to supply maximum output in response to increased demand for health care materials; these include materials for hard surface disinfectant wipes and face masks. In Europe, the company’s meltblown lines are running around the clock to produce materials for face masks and other healthcare applications, such as materials used in blood filtration.
Berry’s position in the supply chain for these health care materials is of critical importance. The company manufactures nonwoven fabrics, which are then sold to converters who produce infection prevention items such as face masks, N95 respirators, and protective apparel.
In addition to its nonwovens supply network, Berry has announced the commercialization of its new Spinlace® production line in Mooresville, N.C. A $50 million investment, the asset is running at full production rates, providing an incremental 17,000 metric tons of annual capacity to the marketplace. The Spinlace asset is focused on various wipes applications serving the health care, hygiene, household cleaning, foodservice and industrial markets.